146 related articles for article (PubMed ID: 26542336)
1. Cardio-oncology and echocardiography-partners in improving patient care.
Wiegers SE
J Am Soc Echocardiogr; 2015 Nov; 28(11):A15. PubMed ID: 26542336
[No Abstract] [Full Text] [Related]
2. [Difficulties in echocardiographic monitoring of trastuzumab therapy in breast cancer patients: case report and review of recommendations].
Duchnowska R; Szmit S; Szczylik C; Opolski G
Kardiol Pol; 2008 Aug; 66(8):895-8. PubMed ID: 18803144
[No Abstract] [Full Text] [Related]
3. Cardio-oncology: Clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancer.
Thuny F; Huttin O; Ederhy S
Arch Cardiovasc Dis; 2019 Oct; 112(10):550-558. PubMed ID: 31522992
[No Abstract] [Full Text] [Related]
4. Is there any cumulative dose for trastuzumab?
Mutlu H; Coşkun HŞ
J Oncol Pharm Pract; 2015 Dec; 21(6):468-70. PubMed ID: 24903272
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of cardiac dysfunction after herceptin treatment in patients with metastatic breast cancer by echocardiography].
Hattori K; Nishi Y; Nakamura S; Misao H; Kikuchi M; Sasaki R; Takeda K
Rinsho Byori; 2007 Feb; 55(2):120-5. PubMed ID: 17390714
[TBL] [Abstract][Full Text] [Related]
6. [Trastuzumab-associated cardiac dysfunction].
Okada Y; Kanbayashi C; Sato N
Gan To Kagaku Ryoho; 2010 Apr; 37(4):665-9. PubMed ID: 20414023
[TBL] [Abstract][Full Text] [Related]
7. Anticancer agents and cardiotoxicity.
Ng R; Better N; Green MD
Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
[TBL] [Abstract][Full Text] [Related]
8. Diastolic dysfunction common among breast cancer patients receiving anthracycline.
Printz C
Cancer; 2015 Oct; 121(20):3563. PubMed ID: 26431440
[No Abstract] [Full Text] [Related]
9. Flaxseed as an Anticardiotoxicity Agent in Breast Cancer Therapy.
Bkaily G; Jacques D
J Nutr; 2020 Sep; 150(9):2231-2232. PubMed ID: 32725201
[No Abstract] [Full Text] [Related]
10. A cardio-oncology experience in Italy: results of a Tuscany regional-based survey.
Canale ML; Camerini A; Magnacca M; Casolo G;
J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):135-40. PubMed ID: 24553090
[TBL] [Abstract][Full Text] [Related]
11. [Chemotherapy-induced cardiac toxicity and management].
Komagata H; Sakai H
Gan To Kagaku Ryoho; 2003 Jun; 30(6):787-92. PubMed ID: 12852345
[TBL] [Abstract][Full Text] [Related]
12. Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab?
Sendur MA; Aksoy S; Ozdemir Y; Zengin N; Altundag K
J BUON; 2013; 18(3):801. PubMed ID: 24065505
[No Abstract] [Full Text] [Related]
13. Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?
Morabito A; Piccirillo MC; De Maio E; Di Maio M; Perrone F
J Clin Oncol; 2009 Sep; 27(27):e123; author reply e124-5. PubMed ID: 19687322
[No Abstract] [Full Text] [Related]
14. Doppler echocardiography during the follow-up of hematological patients undergoing chemotherapy.
Marra F; Galderisi M; Camera A; Rinaldi CR; Innelli P; Rotoli B; de Divitiis O
Int J Cardiol; 2007 Jan; 114(3):403-4. PubMed ID: 16626820
[TBL] [Abstract][Full Text] [Related]
15. Cardiological adverse events after oncological treatment in women.
Zygulska AL; Krzemieniecki K
Przegl Lek; 2012; 69(2):87-9. PubMed ID: 22768421
[TBL] [Abstract][Full Text] [Related]
16. Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?
Ewer MS; Tan-Chiu E
J Clin Oncol; 2007 Dec; 25(34):5532-3; author reply 5533-4. PubMed ID: 18048835
[No Abstract] [Full Text] [Related]
17. [Cardiotoxicity of antineoplastic drugs].
Drzewoski J; Kasznicki J
Acta Haematol Pol; 1992; 23(2):79-86. PubMed ID: 1488864
[TBL] [Abstract][Full Text] [Related]
18. Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.
Khouri MG; Douglas PS; Mackey JR; Martin M; Scott JM; Scherrer-Crosbie M; Jones LW
Circulation; 2012 Dec; 126(23):2749-63. PubMed ID: 23212997
[No Abstract] [Full Text] [Related]
19. Chemotherapy-induced cardiotoxicity in women.
Dempsey KS
Crit Care Nurs Clin North Am; 2008 Sep; 20(3):343-50. PubMed ID: 18644518
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive review on cardio-oncology: Role of multimodality imaging.
Chen-Scarabelli C; McRee C; Leesar MA; Hage FG; Scarabelli TM
J Nucl Cardiol; 2017 Jun; 24(3):906-935. PubMed ID: 27225513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
